Avantor (NYSE:AVTR) Announces Quarterly Earnings Results

Avantor (NYSE:AVTR) issued its quarterly earnings results on Wednesday. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01, RTT News reports. Avantor had a net margin of 4.54% and a return on equity of 12.24%. During the same quarter last year, the firm earned $0.22 EPS.

Avantor Stock Down 1.8 %

AVTR stock opened at $18.06 on Thursday. The stock has a market cap of $12.29 billion, a P/E ratio of 39.26, a PEG ratio of 3.87 and a beta of 1.28. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. Avantor has a twelve month low of $18.00 and a twelve month high of $28.00. The company’s 50 day moving average is $21.63 and its two-hundred day moving average is $23.39.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on AVTR. Royal Bank of Canada cut their target price on shares of Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a research note on Monday. Wells Fargo & Company cut their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday. Stifel Nicolaus decreased their target price on Avantor from $28.00 to $26.00 and set a “buy” rating for the company in a report on Monday. UBS Group restated a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Finally, Morgan Stanley reduced their price target on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Avantor currently has a consensus rating of “Moderate Buy” and a consensus price target of $26.15.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.